Ministry of Education Frontiers Science Center for Precision Oncology, Cancer Centre and Institute of Translational Medicine, Department of Public Health and Medical Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China.
Int J Cancer. 2023 Mar 15;152(6):1159-1173. doi: 10.1002/ijc.34359. Epub 2022 Nov 30.
Pathogenic variation in BRCA1 and BRCA2 (BRCA) causes high risk of breast and ovarian cancer, and BRCA variation data are important markers for BRCA-related clinical cancer applications. However, comprehensive BRCA variation data are lacking from the Asian population despite its large population size, heterogenous genetic background and diversified living environment across the Asia continent. We performed a systematic study on BRCA variation in Asian population including extensive data mining, standardization, annotation and characterization. We identified 7587 BRCA variants from 685 592 Asian individuals in 40 Asia countries and regions, including 1762 clinically actionable pathogenic variants and 4915 functionally unknown variants (https://genemutation.fhs.um.edu.mo/Asian-BRCA/). We observed the highly ethnic-specific nature of Asian BRCA variants between Asian and non-Asian populations and within Asian populations, highlighting that the current European descendant population-based BRCA data is inadequate to reflect BRCA variation in the Asian population. We also provided archeological evidence for the evolutionary origin and arising time of Asian BRCA variation. We further provided structural-based evidence for the deleterious variants enriched within the functionally unknown Asian BRCA variants. The data from our study provide a current view of BRCA variation in the Asian population and a rich resource to guide clinical applications of BRCA-related cancer for the Asian population.
BRCA1 和 BRCA2(BRCA)的致病变异导致乳腺癌和卵巢癌的风险增加,BRCA 变异数据是 BRCA 相关临床癌症应用的重要标志物。然而,尽管亚洲大陆人口众多、遗传背景多样且生活环境多样化,但亚洲人群的综合 BRCA 变异数据仍然缺乏。我们对亚洲人群中的 BRCA 变异进行了系统研究,包括广泛的数据挖掘、标准化、注释和特征描述。我们从 40 个亚洲国家和地区的 685592 名亚洲个体中鉴定出 7587 个 BRCA 变体,包括 1762 个临床上可采取的致病性变体和 4915 个功能未知的变体(https://genemutation.fhs.um.edu.mo/Asian-BRCA/)。我们观察到亚洲 BRCA 变体在亚洲和非亚洲人群之间以及亚洲人群内部具有高度的种族特异性,这表明当前基于欧洲后裔人群的 BRCA 数据不足以反映亚洲人群中的 BRCA 变异。我们还提供了亚洲 BRCA 变异的进化起源和出现时间的考古证据。我们还进一步提供了功能未知的亚洲 BRCA 变体中富含有害变异的结构基础证据。我们的研究数据提供了亚洲人群中 BRCA 变异的最新视图,并为指导亚洲人群中与 BRCA 相关的癌症的临床应用提供了丰富的资源。